$CPAC

Is Cementos Pacasmayo (CPAC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Original reporting
Zacks Commentary · Zacks Equity Research
Published Nov 7, 2025, 2:40 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 8, 2025, 1:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Is Cementos Pacasmayo (CPAC) Stock Undervalued Right Now? — source image
Decision brief

The 30-second read

$CPACBullishMed
01

Why it matters

The article's emphasis on valuation suggests a possible undervaluation, which could attract value investors.

02

Market read

The news is relevant for investors focusing on Latin American construction materials stocks, especially those employing value strategies.

03

What to watch

Potential macroeconomic risks, currency fluctuations, and company-specific operational challenges that could impact future performance.

Timing: long-term

Background

Cementos Pacasmayo operates in the construction materials industry in Peru, with recent focus on valuation and earnings estimates.

Company-level read

Ticker impact

$CPACBullishMedium confidence
Context

The article discusses Cementos Pacasmayo's valuation status, which is relevant for investors interested in the cement industry and Peruvian market.

Expected impact

Moderate upward price movement over the next 3-6 months if valuation gap narrows.

Evidence & confidence

The article emphasizes valuation metrics and earnings estimates, which are favorable for long-term valuation-based strategies. Lack of technical signals and current price data limit short-term trading confidence.

Market effects

Potential positive impact on the construction materials sector in Peru and Latin America.

Limited regional impact due to focus on a specific company and market.

Low; the news is region-specific and pertains to a local market.

Counterpoint

The valuation may already reflect market expectations, and the stock could be overvalued if earnings estimates are overly optimistic.

Key entities

  • Cementos Pacasmayo

    A leading cement producer in Peru.

Related articles

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.

$BKRMed

Baker Hughes (BKR) Lands Multi-Year Contract with Pakistan’s OGDC

Baker Hughes (BKR) secured a multi-year contract with Pakistan's OGDC to enhance production from mature oil and gas fields. The deal involves assessing 120 wells and providing tailored redevelopment plans. Baker Hughes aims to use AI and other technologies to improve flow assurance and restore production. The contract aligns with Baker Hughes' strategy to diversify revenue and reduce reliance on short-term drilling cycles, as evidenced by a 49% YoY increase in orders to $10.5 billion in Q2. Howe

$AAPLMed

Tim Cook Delivered a 2,720% Total Return Over 15 Years. Here's Whether John Ternus Can Do the Same for Apple Investors.

Tim Cook stepped down as Apple CEO after 15 years, delivering 2,720% total returns. New CEO John Ternus faces challenges, including margin pressure from rising memory costs. Apple is set to launch new iPhone models this week. iPhone sales grew over 20% in recent quarters, but management expects slower growth. Apple stock fell on margin concerns despite briefly surpassing $5 trillion.